Bosulif Capsule
Product Images NDC 0069-1014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bosulif (NDC 0069-1014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Bosulif 02)
Logo (Bosulif 03)
This is a description of Pfizer Labs, which is a division of the larger pharmaceutical company Pfizer Inc. The text indicates that Pfizer Labs is responsible for distribution of products, although it does not specify what types of products are being distributed. The address provided is located in New York City.*
Principal Display Panel (100 mg Bottle Label)
This text provides storage instructions along with dosage and usage information for Bosulif tablets. It indicates that the tablets should be stored in a tight, child-resistant container within a certain temperature range. The tablets contain 103.40 mg of bostinib monohydrate equivalent to 100 mg of bosutinib, and they should not be crushed or cut. The document also includes the manufacturer's details, dosage instructions, lot id, NDC number, and GTIN number.*
Principal Display Panel (500 mg Bottle Label)
This is a prescription drug called Bosulif, which comes in the form of tablets containing 516.98mg of bosutinib monohydrate equivalent to 500mg of bosutinib. The tablets should be stored at a temperature of 20-25°C, and can be stored at temperatures between 15-30°C without affecting their efficacy. The medication should be dispensed in tight child-resistant containers. The details of dosage and use can be found in the accompanying prescribing information. Manufactured in Spain and distributed by Pfizer Labs, this drug is labelled for use in oncology and should not be crushed or cut. The text also includes information on the packaging, such as the lot number, NDC (National Drug Code), and GTIN (Global Trade Item Number).*
Principal Display Panel (400 mg Tablet Bottle Label)
"Bosulif" is a medication that contains 413.60mg of bosutinib monohydrate equivalent to 400mg of bosutinib. Each tablet is distributed by Pfizer Labs Division of Pfizer Inc and should be stored at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). It is available in 30-tablet Rx only. Do not crush or cut the tablets, and see accompanying prescribing information. The medication is dispensed in tight (USP), child-resistant containers. GTIN is 00300690193014, and PAA is 078992. The Lot Number is not available. Made in Spain.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.